Empowering Plants with Science
Ascribe develops natural crop protection products that help farmers reduce disease and increase yield without harming the environment or human health.
Why Choose Ascribe?
Ascribe’s products are based on naturally-occurring small molecules from the soil microbiome. Our biobased products are shelf-stable, durable, and more reliable under diverse field conditions than live microbes or complex mixtures. We offer farmers an alternative to toxic chemistry or expensive biologicals.
Safe for the environment and human health
Real results in the field
Flexible to fit modern operations
Our Technology
The core of Ascribe’s technology is a proprietary discovery platform that applies tools of metabolomics to the soil microbiome to identify the small molecules that mediate beneficial interactions between soil microbes and crops.
Ascribe’s lead product, Phytalix®, acts like a vaccine for plants
Phytalix® is based on a naturally-occurring molecule produced by organisms in the soil. Plants react to Phytalix® by priming their defense pathways. Once primed, crops respond more quickly to pathogens and can ward off infection. Phytalix® has proven effective in controlling a broad spectrum of pathogens in lab and field trials across multiple crops like corn, wheat, soy, rice, potatoes, and tomatoes.
Safe
Phytalix® is nontoxic, biodegradable, and non-GMO
Potent
Phytalix® treatments are effective at minimum concentrations requiring only milligrams of active ingredient per acre.
Flexible
Phytalix® can be applied as seed treatment or foliar spray.
About Us
Ascribe Bioscience was founded in 2017 based on discoveries at the Boyce Thompson Institute at Cornell University. We are a team of creative, motivated plant scientists, chemists, agronomists and business professionals. Our mission is to discover and develop natural products for crop protection from the soil microbiome, so farmers can get more reliable, affordable, and sustainable solutions.
Wim Dejonghe
Senior Plant Scientist
Cody Dickinson
Plant Scientist
Jay Farmer
Co-founder & Chief Executive Officer
Ashlyn Amsden
Technician
Dan Klessig
Co-founder
Tom Hayden
Field Trial Manager
Murli Manohar
Co-founder & Chief Technical Officer
Michael Robinson
Process Chemist
Gabriel Wilmoth
Chief Operating Officer
Frank Schroeder
Co-founder
Current Openings:
- none
Latest News
Ascribe Bioscience receives $750,000.00 SBIR Phase II award from NSF
Ascribe Bioscience, which applies the emerging field of metabolomics to the soil microbiome, has won a $750,000 SBIR Phase II award from NSF…
Ascribe Bioscience receives NSF small-business grant
Ascribe Bioscience is the first start-up based on technology developed at the Boyce Thompson Institute (BTI) to receive a NSF SBIR grant.